CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 86 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q1 2020. The put-call ratio across all filers is 0.18 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,728,000 | – | 127,195 | – | 8.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 131,657 | $13,077,000 | 5.92% |
| Point72 Hong Kong Ltd | 103,797 | $10,310,000 | 3.49% |
| York Capital Management Global Advisors, LLC | 827,738 | $82,219,000 | 2.00% |
| Parametrica Management Ltd | 3,889 | $386,000 | 1.83% |
| Athos Capital Ltd | 35,266 | $3,503,000 | 1.19% |
| Hillhouse Capital Management | 618,391 | $61,425,000 | 1.05% |
| JUPITER ASSET MANAGEMENT LTD | 502,812 | $49,940,000 | 0.73% |
| Black Creek Investment Management Inc. | 240,232 | $23,862,000 | 0.73% |
| COMGEST GLOBAL INVESTORS S.A.S. | 243,652 | $24,202,000 | 0.54% |
| Temasek Holdings (Private) Ltd | 990,000 | $98,337,000 | 0.52% |